MiR-24-3p was reported to suppress cellar proliferation in hepatocellular carcinoma (5) as well as promote cellular invasion and migration in nasopharyngeal carcinoma by targeting TEL2 (6) and in lung cancer by targeting SOX7 (7). Here, SOX7 is linked to nasopharyngeal carcinoma.